COLUMBUS, Ohio – Jennifer Carlson, associate vice president for external relations and advocacy at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) has been named first chair of the National Comprehensive Cancer Network® (NCCN®)'s Government Affairs Committee. The appointment became effective in late 2019.
NCCN is a non-profit alliance of 28 leading academic [DR1] cancer centers in the United States and is recognized as the authoritative source of clinical practice-setting guidelines for the treatment of cancer. The organization has developed NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) and the NCCN Drugs & Biologics Compendium (NCCN Compendium®), which is used by the U.S. Centers for Medicaid and Medicare Services (CMS) to help determine coverage for cancer treatment.
In her role as chair of the Governmental Affairs Committee, Carlson will lead a forum to fulfill NCCN’s policy priorities through the development and advancement of state and federal policy and advocacy activities.
Under her leadership, the committee is charged with:
- Identifying stakeholders and points of influence in the legislative and regulatory process;
- Assisting in the development of relationships with key policymakers;
- Organizing participation in relevant NCCN policy activities; and
- Identifying federal and state policy issues impacting NCCN’s policy priorities for the year.
“I am tremendously honored to serve in this leadership role at NCCN. The organization is critical to advancing the necessary policy and practice changes that provide the best care – and rights – to cancer patients and their families,” says Carlson. “This is especially important during this time of rapid progress in oncology treatment, where treatment options are becoming less invasive and more targeted. Policy must be nimble and adapt to ensure that we continue to make progress.”
“The newly-established NCCN Government Affairs Committee will play a crucial role in advancing our mission to improve and facilitate quality, effective, efficient and accessible cancer care through the advancement of better health policy,” says Robert W. Carlson, MD, chief executive officer, NCCN (no relation). “Jennifer Carlson brings a wealth of knowledge and an impressive track record of success in advancing high-quality health policy. Jennifer is passionate about ensuring patients have access to high-quality cancer care. Her experience and dedication will be of great value as she leads the NCCN Government Affairs Committee.”
About the OSUCCC – James
The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) strives to create a cancer-free world by integrating scientific research with excellence in education and patient-centered care, a strategy that leads to better methods of prevention, detection and treatment. Ohio State is one of only 51 National Cancer Institute-designated Comprehensive Cancer Centers and one of only a few centers funded by the NCI to conduct both phase I and phase II clinical trials on novel anticancer drugs. As the cancer program’s 356-bed adult patient-care component, The James is one of the top cancer hospitals in the nation as ranked by U.S. News & World Report and has achieved Magnet® designation, the highest honor an organization can receive for quality patient care and professional nursing practice. With 21 floors comprising more than 1.1 million square feet, The James is a transformational facility that fosters collaboration and integration of cancer research and clinical cancer care.
Amanda J. Harper
OSUCCC – James Media Relations
Direct Line: 614-685-5420
Central Media Relations: 614-293-3737